2022
- ASAN Medical Center Bio Core Facility Funding (Jan)
- IP Voucher Funded by MSS* (March)
- Bio Research Data Funding (April)
- Selected Baby Unicorn 200 Funding (May)
- Series A bridge Funding US$ 3mil. (May)
- Initiated Non Clinical Trial for PLM-102 Candidate
- Initiated Preparation for PLM-401 Phase I trial
2021
- Established Internal Company R&D Lab (Jan)
- Big3 Startup Package Commercialization Funding (Jan)
- IP Voucher Funded by KISTA* (April)
- Bio health Investment-Infra R&D Funding (July)
- PLM-105 selected as NDDP* and Funded by KDDF* (July)
- Licensed In PLM-401 (Dec)
- PLM-401 Phase I IND approved (Dec)
* NDDP: National Drug Development Project
* KDDF: Korea Drug Development Fund
2020
- Moved into Poongjeon Bldg. (Nov)
- Big3 Startup Package R&D Funding (Dec)
- APEX anti tumor PK Advisory Service Funding (Dec)
- Series A Funding US$ 5.5mil. (Dec)
2019
- PeLeMed founded (May)
- Certificate of Venture business (Sep)
- Moved into SEOUL BIOHUB (Nov)
2022
- ASAN Medical Center Bio Core Facility Funding (Jan)
- IP Voucher Funded by MSS* (March)
- Bio Research Data Funding (April)
- Selected Baby Unicorn 200 Funding (May)
- Series A bridge Funding US$ 3mil. (May)
- Initiated Non Clinical Trial for PLM-102 Candidate
- Initiated Preparation for PLM-401 Phase I trial
2021
- Established Internal Company R&D Lab (Jan)
- Big3 Startup Package Commercialization Funding (Jan)
- IP Voucher Funded by KISTA* (April)
- Bio health Investment-Infra R&D Funding (July)
- PLM-105 selected as NDDP* and Funded by KDDF* (July)
- Licensed In PLM-401 (Dec)
- PLM-401 Phase I IND approved (Dec)
* NDDP: National Drug Development Project
* KDDF: Korea Drug Development Fund
2020
- Moved into Poongjeon Bldg. (Nov)
- Big3 Startup Package R&D Funding (Dec)
- APEX anti tumor PK Advisory Service Funding (Dec)
- Series A Funding US$ 5.5mil. (Dec)
2019
- PeLeMed founded (May)
- Certificate of Venture business (Sep)
- Moved into SEOUL BIOHUB (Nov)
2022
- ASAN Medical Center Bio Core Facility Funding (Jan)
- IP Voucher Funded by MSS* (March)
- Bio Research Data Funding (April)
- Selected Baby Unicorn 200 Funding (May)
- Series A bridge Funding US$ 3mil. (May)
- Initiated Non Clinical Trial for PLM-102 Candidate
- Initiated Preparation for PLM-401 Phase I trial
2020
- Moved into Poongjeon Bldg. (Nov)
- Big3 Startup Package R&D Funding (Dec)
- APEX anti tumor PK Advisory Service Funding (Dec)
- Series A Funding US$ 5.5mil. (Dec)
2021
- Established Internal Company R&D Lab (Jan)
- Big3 Startup Package Commercialization Funding (Jan)
- IP Voucher Funded by KISTA* (April)
- Bio health Investment-Infra R&D Funding (July)
- PLM-105 selected as NDDP* and Funded by KDDF* (July)
- Licensed In PLM-401 (Dec)
- PLM-401 Phase I IND approved (Dec)
* NDDP: National Drug Development Project
* KDDF: Korea Drug Development Fund
2019
- PeLeMed founded (May)
- Certificate of Venture business (Sep)
- Moved into SEOUL BIOHUB (Nov)
